Abatacept is a new drug available for refractory Rheumatoid Arthritis (RA), as other biologic therapies this drug is not free of potentially serious adverse events. We present a case of a 73 year-old patient treated with abatacept who suffered a Legionella pneumophila type 1 pneumoniae.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.reuma.2008.10.002 | DOI Listing |
Publication Analysis
Top Keywords
rheumatoid arthritis
8
[legionella patient
4
patient rheumatoid
4
arthritis receiving
4
receiving abatacept]
4
abatacept] abatacept
4
abatacept drug
4
drug refractory
4
refractory rheumatoid
4
arthritis biologic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!